Voyageur Pharmaceuticals Ltd (VM) — Cash Flow Reinvestment Rate

Latest as of November 2024: 0.44x

Voyageur Pharmaceuticals Ltd (VM) has a Cash Flow Reinvestment Rate of 0.44x as of November 2024, reinvesting CA$35.32K (capex CA$0.00 plus investments CA$-35.32K) from operating cash flow of CA$81.14K. Check Voyageur Pharmaceuticals Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.44x

(Capex + Investments) / Operating CF

Total Reinvested

CA$35.32K

Capex + Investments

Operating Cash Flow

CA$81.14K

CAD

Capital Expenditures

CA$0.00

CAD

Voyageur Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2012–2012)

Historical reinvestment intensity for Voyageur Pharmaceuticals Ltd across 1 annual periods. Explore VM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Voyageur Pharmaceuticals Ltd (2012–2012)

Year-by-year capital reinvestment analysis for Voyageur Pharmaceuticals Ltd. For live market cap and broader valuation context, see Voyageur Pharmaceuticals Ltd stock valuation.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2012	0.00x	CA$0.00	CA$2.32K	CA$0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow